14.06.2006 19:00:00

HealthTronics, Inc. Announces Management Changes

HealthTronics, Inc. (NASDAQ:HTRN) today announced thatJames S. B. Whittenburg has been appointed as President - UrologyServices division.

Mr. Whittenburg joined HealthTronics in early 2004 as Senior VicePresident of Development and General Counsel. Since December 2005, Mr.Whittenburg served as President of HealthTronics' specialty vehiclesdivision. Prior to his current position, Mr. Whittenburg was heavilyinvolved with the Company's urology services business. His primaryfocus will be strengthening our physician relationships and drivingvalue in our core business.

Sam B. Humphries, President and Chief Executive Officer, stated,"We are quite pleased that James will be leading our Urology Servicesdivision. He has worked extensively with this division and itsphysician partnerships over the past several years."

Mr. Humphries continued, "Christopher B. Schneider, who previouslyserved a dual role as Chief Operating Officer, Urology ServicesDivision and as President, Medical Device division, will now devotehis full attention to managing the newly-named "Medical Products"division and will serve as its President. The Medical Productsdivision has been expanded to include capital equipment, medicaldevices, anatomical pathology and research & development.

About HealthTronics, Inc.

HealthTronics provides healthcare services primarily to theUrology community, and manufactures and distributes medical products.The Company also manufactures specialty vehicles used for thetransport of high technology medical devices, broadcast &communications equipment and the Homeland Security marketplace. Formore information, visit www.healthtronics.com.

Statements by the Company's management made in this press releasethat are not strictly historical, including statements regardingplans, objective and future financial performance, are"forward-looking" statements that are made pursuant to the safe harborprovisions of the Private Securities Litigation Reform Act of 1995.Although HealthTronics believes that the expectations reflected insuch forward-looking statements are reasonable, no assurance can begiven that the expectations will prove to be correct. Factors thatcould cause actual results to differ materially from HealthTronics'expectations include, among others, the existence of demand for andacceptance of HealthTronics' services, regulatory approvals, economicconditions, the impact of competition and pricing, financing effortsand other factors described from time to time in HealthTronics'periodic filings with the Securities and Exchange Commission.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu HealthTronics Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu HealthTronics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 161,63 -1,63%